NO305834B1 - 4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler - Google Patents
4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidlerInfo
- Publication number
- NO305834B1 NO305834B1 NO960392A NO960392A NO305834B1 NO 305834 B1 NO305834 B1 NO 305834B1 NO 960392 A NO960392 A NO 960392A NO 960392 A NO960392 A NO 960392A NO 305834 B1 NO305834 B1 NO 305834B1
- Authority
- NO
- Norway
- Prior art keywords
- mercaptobenzoylguanidines
- pharmaceuticals
- compounds
- manufacture
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Testing Resistance To Weather, Investigating Materials By Mechanical Methods (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19502895A DE19502895A1 (de) | 1995-01-31 | 1995-01-31 | 4-Mercapto-benzoylguanidin-Derivate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO960392D0 NO960392D0 (no) | 1996-01-30 |
| NO960392L NO960392L (no) | 1996-08-01 |
| NO305834B1 true NO305834B1 (no) | 1999-08-02 |
Family
ID=7752677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO960392A NO305834B1 (no) | 1995-01-31 | 1996-01-30 | 4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5696167A (cs) |
| EP (1) | EP0725062B1 (cs) |
| JP (1) | JP3770947B2 (cs) |
| CN (1) | CN1058001C (cs) |
| AR (1) | AR002954A1 (cs) |
| AT (1) | ATE202088T1 (cs) |
| AU (1) | AU706843B2 (cs) |
| BR (1) | BR9600263A (cs) |
| CA (1) | CA2168319C (cs) |
| CO (1) | CO4700519A1 (cs) |
| CZ (1) | CZ290184B6 (cs) |
| DE (2) | DE19502895A1 (cs) |
| DK (1) | DK0725062T3 (cs) |
| ES (1) | ES2159652T3 (cs) |
| FI (1) | FI960423L (cs) |
| GR (1) | GR3036344T3 (cs) |
| HU (1) | HUP9600213A3 (cs) |
| NO (1) | NO305834B1 (cs) |
| PL (1) | PL181311B1 (cs) |
| PT (1) | PT725062E (cs) |
| RU (1) | RU2162079C2 (cs) |
| SI (1) | SI0725062T1 (cs) |
| SK (1) | SK281199B6 (cs) |
| TR (1) | TR199600067A2 (cs) |
| TW (1) | TW432036B (cs) |
| UA (1) | UA43345C2 (cs) |
| ZA (1) | ZA96701B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4328352A1 (de) | 1993-08-24 | 1995-03-02 | Hoechst Ag | Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP1131064A2 (en) * | 1998-11-26 | 2001-09-12 | MERCK PATENT GmbH | Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus |
| DE19859727A1 (de) | 1998-12-23 | 2000-06-29 | Aventis Pharma Gmbh | Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung |
| DE19951418A1 (de) * | 1999-10-26 | 2001-05-03 | Merck Patent Gmbh | Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid |
| TWI402261B (zh) | 2006-06-19 | 2013-07-21 | Takeda Pharmaceutical | 三環化合物及其醫藥組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| ES2108144T3 (es) * | 1992-02-15 | 1997-12-16 | Hoechst Ag | Benzoilguanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. |
| CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
| EP0589336B1 (de) * | 1992-09-22 | 1997-01-08 | Hoechst Aktiengesellschaft | Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika |
| TW250477B (cs) * | 1992-12-15 | 1995-07-01 | Hoechst Ag | |
| TW250479B (cs) * | 1992-12-15 | 1995-07-01 | Hoechst Ag | |
| US5458948A (en) * | 1992-12-18 | 1995-10-17 | Konica Corporation | Magnetic recording medium |
| DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4318756A1 (de) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4328869A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1995
- 1995-01-31 DE DE19502895A patent/DE19502895A1/de not_active Withdrawn
-
1996
- 1996-01-19 DE DE59607055T patent/DE59607055D1/de not_active Expired - Lifetime
- 1996-01-19 ES ES96100764T patent/ES2159652T3/es not_active Expired - Lifetime
- 1996-01-19 PT PT96100764T patent/PT725062E/pt unknown
- 1996-01-19 EP EP96100764A patent/EP0725062B1/de not_active Expired - Lifetime
- 1996-01-19 AT AT96100764T patent/ATE202088T1/de not_active IP Right Cessation
- 1996-01-19 DK DK96100764T patent/DK0725062T3/da active
- 1996-01-19 SI SI9630327T patent/SI0725062T1/xx unknown
- 1996-01-20 TW TW085100660A patent/TW432036B/zh active
- 1996-01-25 AU AU42200/96A patent/AU706843B2/en not_active Ceased
- 1996-01-26 AR ARP960101167A patent/AR002954A1/es unknown
- 1996-01-26 TR TR96/00067A patent/TR199600067A2/xx unknown
- 1996-01-29 UA UA96010340A patent/UA43345C2/uk unknown
- 1996-01-29 CA CA002168319A patent/CA2168319C/en not_active Expired - Fee Related
- 1996-01-29 SK SK128-96A patent/SK281199B6/sk unknown
- 1996-01-30 BR BR9600263A patent/BR9600263A/pt not_active Application Discontinuation
- 1996-01-30 RU RU96101794/04A patent/RU2162079C2/ru not_active IP Right Cessation
- 1996-01-30 CZ CZ1996277A patent/CZ290184B6/cs not_active IP Right Cessation
- 1996-01-30 FI FI960423A patent/FI960423L/fi unknown
- 1996-01-30 HU HU9600213A patent/HUP9600213A3/hu unknown
- 1996-01-30 CN CN96101110A patent/CN1058001C/zh not_active Expired - Fee Related
- 1996-01-30 PL PL96312544A patent/PL181311B1/pl unknown
- 1996-01-30 ZA ZA96701A patent/ZA96701B/xx unknown
- 1996-01-30 NO NO960392A patent/NO305834B1/no unknown
- 1996-01-30 US US08/593,863 patent/US5696167A/en not_active Expired - Lifetime
- 1996-01-31 JP JP03584896A patent/JP3770947B2/ja not_active Expired - Fee Related
- 1996-01-31 CO CO96004146A patent/CO4700519A1/es unknown
-
2001
- 2001-08-07 GR GR20010401196T patent/GR3036344T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO305906B1 (no) | Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler | |
| NO944700D0 (no) | Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene | |
| NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
| FI943687L (fi) | Uudet 11-bentsaldoksiimiestradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet | |
| NO965377D0 (no) | Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene | |
| NO305907B1 (no) | Forbindelser, forbindelser for bekjempelse av sykdommer, legemidler som endotelinreseptorantagonist, farmasöytiske preparater samt anvendelse av slike forbindelser til fremstilling av legemidler | |
| DK0807111T3 (da) | Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse | |
| NO306725B1 (no) | Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler | |
| AR027162A1 (es) | Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen | |
| NO307459B1 (no) | Piperazinderivater, samt farmasøytiske preparater inneholdende slike | |
| NO923434L (no) | 1,2-dihydro-2-oksopyridiner, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater som inneholder minst en slik forbindelse | |
| FI943570A0 (fi) | 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita | |
| BR9606674B1 (pt) | novo derivado de composto de antraciclina e preparação farmacêutica contendo o mesmo. | |
| NO980059L (no) | Nye oksazolidinonderivater, fremgangsmåte for fremstilling av dem, samt medikamenter som inneholder disse forbindelsene | |
| NO306113B1 (no) | Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler | |
| FI943688L (fi) | Uudet 11-bentsaldoksiimi-17beta-metoksi-27alfa-metoksi-metyyli-estradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä sisältävät lääkeaineet | |
| NO302368B1 (no) | Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene | |
| FI954986L (fi) | Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet | |
| NO942910L (no) | Nye baccatin-III- og 10-desacetyl-baccatin-III-derivater, deres fremstillinger, samt farmasöytiske preparater inneholdende derivatene | |
| NO305286B1 (no) | Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter | |
| IS4780A (is) | Þíól afleiður með málmpeptíðasa letjandi virkni, aðferð til framleiðslu þeirra, lyfjaefnablöndur sem innihalda slíkt efnasamband, ásamt notkun á efnasamböndunum til framleiðslu á lyfjum | |
| NO305836B1 (no) | Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler | |
| NO305793B1 (no) | 4-aminobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler | |
| NO983540D0 (no) | Farmas°ytiske preparater av cilansetron som er stabilisert mot racemisering | |
| NO305834B1 (no) | 4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler |